Evidence map›Paper›PMID 31654206›Full record

ArticleWorld journal of microbiology & biotechnology2019

Aberrant methylation of host macrophages induced by tuberculosis infection.

Ava Behrouzi, Shima Hadifar, Amir Amanzadeh, Farhad Riazi Rad, Farzam Vaziri, Seyed Davar Siadat

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Antibiotic Resistance toAntibiotics (Basel, Switzerland) · 2022
    Review
  2. Evolution of Drug-ResistantFrontiers in microbiology · 2021
    Review
  3. Host Epigenetics in Intracellular Pathogen Infections.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ava BehrouziDepartment of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Shima HadifarDepartment of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Amir AmanzadehNational Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran.
Farhad Riazi RadDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Farzam VaziriDepartment of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Seyed Davar SiadatDepartment of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran. siadat@pasteur.ac.ir.
Pasteur Institute of Iran · IR

Funding

Pasteur Institute of Iran 1006
6 · The paper itself

Abstract

DNA methylation has been introduced as a promising biomarker for different diseases. Alterations in macrophage DNA methylation status have been documented during Mycobacterium tuberculosis (Mtb) infection. We conducted this study using a human methylation PCR array kit, which comprised a panel of 22 genes in TLR2 signaling pathway, in order to gain insights into epigenetic interactions between drug-susceptible and -resistant Mtb strains and THP-1-derived macrophages (one of the main host immunity cells during TB infection). We also evaluated the expression of Rv1988 gene in the studied isolates. It was found that the methylation level of all of the studied inflammatory genes, except Irak-2 and Tbk-1, increased in THP-1 macrophages, which were infected by extensively drug-resistant (XDR) Mtb strains, compared with the mock cells (P < 0.05). In susceptible strains, we only found hypomethylation in Irak-2 gene, in addition to a slight increase in the methylation levels of Ubev, Ube2n, and Traf6 genes. The present findings provide new insights into the potential role of resistant and susceptible Mtb strains in promoting aberrant epigenetic modifications in macrophages. Further investigations on the host epigenomes, infected with different Mtb isolates, are needed to elucidate their functions in immunological responses and to introduce new effective tools against Mtb infection.

Indexed as

DNA MethylationEpigenesis, GeneticAntitubercular AgentsBacterial ProteinsExtensively Drug-Resistant TuberculosisGene Expression Regulation, BacterialHost-Pathogen InteractionsHumansInterleukin-1 Receptor-Associated KinasesIntracellular Signaling Peptides and ProteinsMacrophagesMethyltransferasesMycobacterium tuberculosisProtein Serine-Threonine KinasesSignal TransductionTHP-1 CellsAntitubercular AgentsBacterial ProteinsInterleukin-1 Receptor-Associated KinasesIntracellular Signaling Peptides and ProteinsMethyltransferasesProtein Serine-Threonine KinasesRv1988 protein, Mycobacterium tuberculosisTBK1 protein, humanTifab protein, humanTLR2 protein, humanTNF Receptor-Associated Factor 6Toll-Like Receptor 2UBE2N protein, humanUbiquitin-Conjugating EnzymesDNA methylationMycobacterium tuberculosisSignaling pathwayTHP1

Identifiers

PMID31654206
OpenAlexW2981345494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.